The Adjunctive Use of Lavender and Peppermint Essential Oils

This study will use passive inhalation of lavender for discomfort, anxiety and peppermint for nausea following joint replacement and spine surgery

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Joint Diseases Musculoskeletal Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University Hospitals of Cleveland

Cleveland, Ohio, 44106, United States

About this study

Following review of records for eligibility and consent obtained during pre op visit subjects will be enrolled in study post op they will validate desire to participate and chose to inhale (2 drops of essential oil on cotton ball in a plastic bag) lavender for discomfort or anxiety or peppermint for GI distress

Visual analogue scales will be used to rate discomfort , anxiety and nausea

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

elective joint replacement able to read and speak English and describe study procedures

Exclusion criteria

pregnancy

unable to smell, sensitivity to fragrances asthma or breathing problems have smoke or vaped in last 2 weeks if atrial fibrillation history no peppermint uncontrolled hypertension above 160/100 non employees of UH or students of CWRU

Treatment and study plan

Adjunctive use of lavender and peppermint essential oils

Dietary Supplement

passive inhalation aromatherapy following joint surgery

Other names: aromatherapy

Primary outcomes

discomfort, anxiety, or GI distress

Time frame: total of 90 minutes

visual analog sale

Sponsors and collaborators

Lead sponsor

University Hospitals Cleveland Medical Center

Other

Registry information

Official study title

The Adjunctive Use of Lavender and Peppermint Essential Oils to Manage Nausea, Pain, and Anxiety in an Adult Orthopedic Population

Acronym: aromatherapy

Important dates

Study start: 2021
Primary completion: 2023
Study completion: 2023
First posted: Jun 22, 2021
Registry last updated: Apr 11, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed